Wednesday, January 24, 2018

Senate Confirms Alex Azar As The Next HHS Secretary.

The New York Times (1/24, Pear, Subscription Publication) reports that on Wednesday, by a vote of 55-43, the Senate confirmed Alex Azar as the new HHS Secretary. The article says Azar, who is a former executive at Eli Lilly, “faces two huge challenges.” He must find a way to reduce drug prices, and determine how to handle the ACA, “a task for which he will be personally and legally responsible.”

The Los Angeles Times (1/24, Levey) reports that Azar has vowed “to prioritize key issues important to both Republicans and Democrats, including the opioid epidemic, the burden of healthcare costs on Americans and the rising price of pharmaceuticals.” However, because Lilly dramatically increased the price of its insulin product during Azar’s tenure, “many consumer advocates [are] skeptical he will take on the powerful pharmaceutical industry.”

Author: Nicole Hardy

Categories: 2018, January, News, AdvocacyNumber of views: 7037